Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.89156180 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.89156180 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64094717 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.64094717 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.22751066 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.83894474 |
7 | glyoxylate metabolic process (GO:0046487) | 5.69135561 |
8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68213695 |
9 | tryptophan catabolic process (GO:0006569) | 5.61583186 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.61583186 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.61583186 |
12 | kynurenine metabolic process (GO:0070189) | 5.49259358 |
13 | bile acid biosynthetic process (GO:0006699) | 5.41785280 |
14 | tryptophan metabolic process (GO:0006568) | 5.32711832 |
15 | cysteine metabolic process (GO:0006534) | 5.32081291 |
16 | sulfur amino acid catabolic process (GO:0000098) | 5.25729074 |
17 | urea metabolic process (GO:0019627) | 5.22482461 |
18 | urea cycle (GO:0000050) | 5.22482461 |
19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.13292906 |
20 | protein carboxylation (GO:0018214) | 5.13292906 |
21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.12260267 |
22 | negative regulation of fibrinolysis (GO:0051918) | 5.03484786 |
23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.01538393 |
24 | lysine catabolic process (GO:0006554) | 4.94576198 |
25 | lysine metabolic process (GO:0006553) | 4.94576198 |
26 | complement activation, alternative pathway (GO:0006957) | 4.86991440 |
27 | serine family amino acid catabolic process (GO:0009071) | 4.82523604 |
28 | regulation of protein activation cascade (GO:2000257) | 4.81538840 |
29 | homocysteine metabolic process (GO:0050667) | 4.80715983 |
30 | nitrogen cycle metabolic process (GO:0071941) | 4.78714784 |
31 | regulation of fibrinolysis (GO:0051917) | 4.74357397 |
32 | bile acid metabolic process (GO:0008206) | 4.65979761 |
33 | * amino-acid betaine metabolic process (GO:0006577) | 4.54903093 |
34 | reverse cholesterol transport (GO:0043691) | 4.54690731 |
35 | regulation of complement activation (GO:0030449) | 4.51793056 |
36 | regulation of triglyceride catabolic process (GO:0010896) | 4.51000679 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.50026973 |
38 | regulation of cholesterol esterification (GO:0010872) | 4.44208493 |
39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.39306971 |
40 | protein-lipid complex remodeling (GO:0034368) | 4.39306971 |
41 | macromolecular complex remodeling (GO:0034367) | 4.39306971 |
42 | negative regulation of cholesterol transport (GO:0032375) | 4.34641547 |
43 | negative regulation of sterol transport (GO:0032372) | 4.34641547 |
44 | tyrosine metabolic process (GO:0006570) | 4.33983166 |
45 | phospholipid efflux (GO:0033700) | 4.32998240 |
46 | alpha-amino acid catabolic process (GO:1901606) | 4.31115892 |
47 | acylglycerol homeostasis (GO:0055090) | 4.22491353 |
48 | triglyceride homeostasis (GO:0070328) | 4.22491353 |
49 | cellular ketone body metabolic process (GO:0046950) | 4.17556122 |
50 | drug catabolic process (GO:0042737) | 4.12801555 |
51 | cellular glucuronidation (GO:0052695) | 4.11895287 |
52 | plasma lipoprotein particle clearance (GO:0034381) | 4.11890136 |
53 | ethanol oxidation (GO:0006069) | 4.04695241 |
54 | cellular amino acid catabolic process (GO:0009063) | 4.03171202 |
55 | bile acid and bile salt transport (GO:0015721) | 4.02640573 |
56 | cellular modified amino acid catabolic process (GO:0042219) | 4.01925828 |
57 | glycine metabolic process (GO:0006544) | 3.98951317 |
58 | serine family amino acid metabolic process (GO:0009069) | 3.97509642 |
59 | drug transmembrane transport (GO:0006855) | 3.96359932 |
60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.96020137 |
61 | benzene-containing compound metabolic process (GO:0042537) | 3.94707653 |
62 | glutamate metabolic process (GO:0006536) | 3.94526244 |
63 | regulation of cholesterol homeostasis (GO:2000188) | 3.93931734 |
64 | indolalkylamine metabolic process (GO:0006586) | 3.93646732 |
65 | cholesterol efflux (GO:0033344) | 3.88224980 |
66 | urate metabolic process (GO:0046415) | 3.86525548 |
67 | phospholipid homeostasis (GO:0055091) | 3.85337804 |
68 | short-chain fatty acid metabolic process (GO:0046459) | 3.79673259 |
69 | coenzyme catabolic process (GO:0009109) | 3.78704043 |
70 | plasma lipoprotein particle assembly (GO:0034377) | 3.78551886 |
71 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77092327 |
72 | cellular biogenic amine catabolic process (GO:0042402) | 3.76578732 |
73 | amine catabolic process (GO:0009310) | 3.76578732 |
74 | fibrinolysis (GO:0042730) | 3.71957217 |
75 | glucuronate metabolic process (GO:0019585) | 3.70262291 |
76 | uronic acid metabolic process (GO:0006063) | 3.70262291 |
77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69292374 |
78 | serine family amino acid biosynthetic process (GO:0009070) | 3.68509750 |
79 | imidazole-containing compound metabolic process (GO:0052803) | 3.68492996 |
80 | aldehyde catabolic process (GO:0046185) | 3.63667044 |
81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63008757 |
82 | exogenous drug catabolic process (GO:0042738) | 3.62380472 |
83 | arginine metabolic process (GO:0006525) | 3.62367856 |
84 | * carboxylic acid catabolic process (GO:0046395) | 3.60791678 |
85 | * organic acid catabolic process (GO:0016054) | 3.60791678 |
86 | cholesterol homeostasis (GO:0042632) | 3.60703332 |
87 | ketone body metabolic process (GO:1902224) | 3.59907027 |
88 | mannose metabolic process (GO:0006013) | 3.58360020 |
89 | flavonoid metabolic process (GO:0009812) | 3.56789988 |
90 | sterol homeostasis (GO:0055092) | 3.56435768 |
91 | acetyl-CoA metabolic process (GO:0006084) | 3.54994574 |
92 | regulation of bile acid biosynthetic process (GO:0070857) | 3.54474745 |
93 | * fatty acid beta-oxidation (GO:0006635) | 3.53397959 |
94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53252284 |
95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53252284 |
96 | * fatty acid oxidation (GO:0019395) | 3.52703416 |
97 | epoxygenase P450 pathway (GO:0019373) | 3.48450756 |
98 | * lipid oxidation (GO:0034440) | 3.46814280 |
99 | valine metabolic process (GO:0006573) | 3.46810716 |
100 | desmosome organization (GO:0002934) | 3.46539767 |
101 | aspartate family amino acid catabolic process (GO:0009068) | 3.46046734 |
102 | protein-lipid complex assembly (GO:0065005) | 3.44961217 |
103 | * monocarboxylic acid catabolic process (GO:0072329) | 3.44948462 |
104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.44869783 |
105 | Golgi transport vesicle coating (GO:0048200) | 3.44831135 |
106 | COPI coating of Golgi vesicle (GO:0048205) | 3.44831135 |
107 | negative regulation of fatty acid transport (GO:2000192) | 3.33198645 |
108 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.20003120 |
109 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.11390365 |
110 | angiotensin maturation (GO:0002003) | 3.02216200 |
111 | iron ion import (GO:0097286) | 3.00902126 |
112 | hepatocyte apoptotic process (GO:0097284) | 2.85990717 |
113 | embryonic process involved in female pregnancy (GO:0060136) | 2.83086657 |
114 | NADH metabolic process (GO:0006734) | 2.81231181 |
115 | proline biosynthetic process (GO:0006561) | 2.80634391 |
116 | negative regulation of cell size (GO:0045792) | 2.76335525 |
117 | regulation of integrin activation (GO:0033623) | 2.73905657 |
118 | hormone catabolic process (GO:0042447) | 2.73686895 |
119 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.67515468 |
120 | pinocytosis (GO:0006907) | 2.67273425 |
121 | epithelial cell-cell adhesion (GO:0090136) | 2.63768463 |
122 | glycosphingolipid catabolic process (GO:0046479) | 2.63545201 |
123 | intestinal absorption (GO:0050892) | 2.61585015 |
124 | definitive hemopoiesis (GO:0060216) | 2.55096199 |
125 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.54930298 |
126 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.54190833 |
127 | ethanol metabolic process (GO:0006067) | 2.50696835 |
128 | regulation of vitamin metabolic process (GO:0030656) | 2.48411863 |
129 | response to thyroid hormone (GO:0097066) | 2.48198523 |
130 | protein localization to endosome (GO:0036010) | 2.45337886 |
131 | omega-hydroxylase P450 pathway (GO:0097267) | 2.45073326 |
132 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41995670 |
133 | glycolipid catabolic process (GO:0019377) | 2.40425304 |
134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.40157747 |
135 | intestinal epithelial cell development (GO:0060576) | 2.39735200 |
136 | amyloid precursor protein catabolic process (GO:0042987) | 2.38637833 |
137 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.38363730 |
138 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.36662086 |
139 | peptide catabolic process (GO:0043171) | 2.36284706 |
140 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.35462200 |
141 | regulation of histone H3-K27 methylation (GO:0061085) | 2.35019147 |
142 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.34299384 |
143 | glucose 6-phosphate metabolic process (GO:0051156) | 2.34298048 |
144 | regulation of water loss via skin (GO:0033561) | 2.34040711 |
145 | renal filtration (GO:0097205) | 2.32741192 |
146 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.32511231 |
147 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.31094544 |
148 | glucose catabolic process (GO:0006007) | 2.29648760 |
149 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.28726200 |
150 | regulation of leukocyte degranulation (GO:0043300) | 2.28507913 |
151 | glomerular filtration (GO:0003094) | 2.27314429 |
152 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.27224358 |
153 | pentose-phosphate shunt (GO:0006098) | 2.25757750 |
154 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.24091258 |
155 | maternal placenta development (GO:0001893) | 2.22520334 |
156 | response to food (GO:0032094) | 2.22175105 |
157 | sphingomyelin metabolic process (GO:0006684) | 2.21012076 |
158 | activation of Rac GTPase activity (GO:0032863) | 2.20887206 |
159 | proline metabolic process (GO:0006560) | 2.20583715 |
160 | regulation of extracellular matrix disassembly (GO:0010715) | 2.18407234 |
161 | response to peptidoglycan (GO:0032494) | 2.17797129 |
162 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.17278792 |
163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.16457581 |
164 | hyaluronan catabolic process (GO:0030214) | 2.16384696 |
165 | multicellular organismal water homeostasis (GO:0050891) | 2.14543345 |
166 | positive regulation of histone deacetylation (GO:0031065) | 2.13926414 |
167 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.13601981 |
168 | negative regulation of viral release from host cell (GO:1902187) | 2.13018400 |
169 | auditory receptor cell differentiation (GO:0042491) | 2.11778186 |
170 | positive regulation of extracellular matrix organization (GO:1903055) | 2.11234041 |
171 | negative regulation of interleukin-8 production (GO:0032717) | 2.11018991 |
172 | regulation of cholesterol metabolic process (GO:0090181) | 2.09699343 |
173 | striated muscle atrophy (GO:0014891) | 2.08771396 |
174 | citrulline biosynthetic process (GO:0019240) | 2.08628288 |
175 | COPII vesicle coating (GO:0048208) | 2.08247242 |
176 | response to laminar fluid shear stress (GO:0034616) | 2.06715676 |
177 | oxaloacetate metabolic process (GO:0006107) | 2.06532963 |
178 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.05722878 |
179 | regulation of keratinocyte differentiation (GO:0045616) | 2.05702896 |
180 | response to water (GO:0009415) | 2.05229224 |
181 | regulation of viral release from host cell (GO:1902186) | 2.04379949 |
182 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.03812453 |
183 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.02490683 |
184 | complement activation, classical pathway (GO:0006958) | 2.02459951 |
185 | trophectodermal cell differentiation (GO:0001829) | 2.02287825 |
186 | citrulline metabolic process (GO:0000052) | 2.01963403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.63472552 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.66591961 |
3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.98963199 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.81260268 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.99402290 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.67091857 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.25086526 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.66539966 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.29831113 |
10 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.40882527 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35391693 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25916467 |
13 | MYC_22102868_ChIP-Seq_BL_Human | 2.18099350 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17973677 |
15 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6611386 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98316159 |
17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.95502912 |
18 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94907005 |
19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94128370 |
20 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91634178 |
21 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91580711 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84012674 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79862278 |
24 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73055089 |
25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68185279 |
26 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.65317830 |
27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63520461 |
28 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63270079 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56161259 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51867180 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51824791 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51210607 |
33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46183499 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42350499 |
35 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.42332006 |
36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37902371 |
37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37268822 |
38 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37141464 |
39 | MAF_26560356_Chip-Seq_TH1_Human | 1.34635786 |
40 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30888670 |
41 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25974788 |
42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24634273 |
43 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23813685 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23317789 |
45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22651855 |
46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21354211 |
47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20353137 |
48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17400892 |
49 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.15695894 |
50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15451948 |
51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15320976 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14075263 |
53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13222532 |
54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12796852 |
55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11838847 |
56 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10713537 |
57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09006116 |
58 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08906081 |
59 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08906081 |
60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08359500 |
61 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08090290 |
62 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07385399 |
63 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06539491 |
64 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.06463566 |
65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05315800 |
66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05260595 |
67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04704188 |
68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04589552 |
69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04500468 |
70 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04267246 |
71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03535098 |
72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02396996 |
73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01152122 |
74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00214344 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99093808 |
76 | * P68_20966046_ChIP-Seq_HELA_Human | 0.98873015 |
77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98521897 |
78 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98334152 |
79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93728408 |
80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93723307 |
81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91187732 |
82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89047405 |
83 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88925661 |
84 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86853155 |
85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86562231 |
86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86397772 |
87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85225928 |
88 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84277156 |
89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82682123 |
90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81401138 |
91 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80153422 |
92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78708790 |
93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78687379 |
94 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78093698 |
95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76624434 |
96 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76473055 |
97 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74441126 |
98 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.74055983 |
99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73551760 |
100 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72930230 |
101 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72069373 |
102 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70086915 |
103 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.67742304 |
104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67427657 |
105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.67382909 |
106 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67242032 |
107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66624121 |
108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.65533378 |
109 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.64461479 |
110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.62920683 |
111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62902491 |
112 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62845570 |
113 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62184909 |
114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.61659324 |
115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60575794 |
116 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60061279 |
117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58343183 |
118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58119387 |
119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.57811774 |
120 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57297936 |
121 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.57297936 |
122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57266424 |
123 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56908623 |
124 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56908623 |
125 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56346550 |
126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56054267 |
127 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56033033 |
128 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55640291 |
129 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.54812311 |
130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54413983 |
131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54082426 |
132 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.53645424 |
133 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.53517586 |
134 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52869145 |
135 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52828386 |
136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.52812965 |
137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.51657836 |
138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.50337625 |
139 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.48891446 |
140 | ATF3_27146783_Chip-Seq_COLON_Human | 0.48829989 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.49158971 |
2 | MP0005360_urolithiasis | 7.15987304 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.68271801 |
4 | MP0005365_abnormal_bile_salt | 5.62022454 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.83459042 |
6 | MP0003252_abnormal_bile_duct | 3.73832280 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.47050055 |
8 | MP0010329_abnormal_lipoprotein_level | 3.33444545 |
9 | MP0009840_abnormal_foam_cell | 3.20149501 |
10 | MP0005332_abnormal_amino_acid | 2.82751080 |
11 | MP0003195_calcinosis | 2.74752487 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.63396646 |
13 | MP0005083_abnormal_biliary_tract | 2.62600697 |
14 | MP0001666_abnormal_nutrient_absorption | 2.48248334 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.37999777 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.20553073 |
17 | MP0005409_darkened_coat_color | 2.19696243 |
18 | MP0003183_abnormal_peptide_metabolism | 2.11774355 |
19 | MP0000609_abnormal_liver_physiology | 2.10985832 |
20 | * MP0002118_abnormal_lipid_homeostasis | 1.96137936 |
21 | MP0002396_abnormal_hematopoietic_system | 1.91573920 |
22 | MP0002877_abnormal_melanocyte_morpholog | 1.90425109 |
23 | MP0001873_stomach_inflammation | 1.90082679 |
24 | MP0005319_abnormal_enzyme/_coenzyme | 1.85904569 |
25 | MP0002009_preneoplasia | 1.84230738 |
26 | MP0010352_gastrointestinal_tract_polyps | 1.73133542 |
27 | MP0005076_abnormal_cell_differentiation | 1.68376729 |
28 | MP0009643_abnormal_urine_homeostasis | 1.64621271 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.61666767 |
30 | MP0003868_abnormal_feces_composition | 1.61471272 |
31 | MP0003011_delayed_dark_adaptation | 1.55701856 |
32 | MP0003866_abnormal_defecation | 1.52937553 |
33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51190805 |
34 | MP0001764_abnormal_homeostasis | 1.51039234 |
35 | MP0003172_abnormal_lysosome_physiology | 1.38272626 |
36 | MP0003186_abnormal_redox_activity | 1.33338281 |
37 | MP0001835_abnormal_antigen_presentation | 1.29191936 |
38 | MP0003763_abnormal_thymus_physiology | 1.24742196 |
39 | MP0004185_abnormal_adipocyte_glucose | 1.24047403 |
40 | MP0002098_abnormal_vibrissa_morphology | 1.22946660 |
41 | MP0000598_abnormal_liver_morphology | 1.22883100 |
42 | MP0005501_abnormal_skin_physiology | 1.22121221 |
43 | MP0010368_abnormal_lymphatic_system | 1.22038399 |
44 | MP0003303_peritoneal_inflammation | 1.21836956 |
45 | MP0002254_reproductive_system_inflammat | 1.21469666 |
46 | MP0002006_tumorigenesis | 1.19279279 |
47 | MP0000858_altered_metastatic_potential | 1.18570624 |
48 | MP0003656_abnormal_erythrocyte_physiolo | 1.17500780 |
49 | MP0005025_abnormal_response_to | 1.17410800 |
50 | MP0005451_abnormal_body_composition | 1.16740644 |
51 | MP0009764_decreased_sensitivity_to | 1.14680632 |
52 | MP0008438_abnormal_cutaneous_collagen | 1.13299223 |
53 | MP0001849_ear_inflammation | 1.09677702 |
54 | MP0003300_gastrointestinal_ulcer | 1.09189235 |
55 | MP0005636_abnormal_mineral_homeostasis | 1.08782595 |
56 | MP0004858_abnormal_nervous_system | 1.06935448 |
57 | MP0005670_abnormal_white_adipose | 1.05248907 |
58 | MP0001533_abnormal_skeleton_physiology | 1.04943477 |
59 | MP0010678_abnormal_skin_adnexa | 1.04274417 |
60 | MP0009763_increased_sensitivity_to | 1.03305992 |
61 | MP0001881_abnormal_mammary_gland | 1.03002099 |
62 | MP0004808_abnormal_hematopoietic_stem | 1.02871506 |
63 | MP0008469_abnormal_protein_level | 1.02612268 |
64 | MP0005647_abnormal_sex_gland | 1.02459035 |
65 | MP0000465_gastrointestinal_hemorrhage | 1.02250136 |
66 | MP0003828_pulmonary_edema | 1.00439747 |
67 | MP0001216_abnormal_epidermal_layer | 0.99350044 |
68 | MP0001756_abnormal_urination | 0.97922087 |
69 | MP0000604_amyloidosis | 0.97561410 |
70 | MP0008260_abnormal_autophagy | 0.97560060 |
71 | MP0000685_abnormal_immune_system | 0.97543696 |
72 | MP0003091_abnormal_cell_migration | 0.97357828 |
73 | MP0000627_abnormal_mammary_gland | 0.97180443 |
74 | MP0009780_abnormal_chondrocyte_physiolo | 0.97050274 |
75 | MP0000490_abnormal_crypts_of | 0.96113901 |
76 | MP0003045_fibrosis | 0.93197723 |
77 | MP0004233_abnormal_muscle_weight | 0.92495801 |
78 | MP0005397_hematopoietic_system_phenotyp | 0.91505037 |
79 | MP0001545_abnormal_hematopoietic_system | 0.91505037 |
80 | MP0000477_abnormal_intestine_morphology | 0.90515328 |
81 | MP0009278_abnormal_bone_marrow | 0.88756496 |
82 | MP0002136_abnormal_kidney_physiology | 0.88093464 |
83 | MP0009697_abnormal_copulation | 0.87616642 |
84 | MP0009931_abnormal_skin_appearance | 0.87393025 |
85 | * MP0009642_abnormal_blood_homeostasis | 0.87172709 |
86 | MP0002998_abnormal_bone_remodeling | 0.85734367 |
87 | MP0004130_abnormal_muscle_cell | 0.85547674 |
88 | MP0001664_abnormal_digestion | 0.85374542 |
89 | MP0001851_eye_inflammation | 0.85161874 |
90 | MP0000467_abnormal_esophagus_morphology | 0.84995202 |
91 | MP0009785_altered_susceptibility_to | 0.84765156 |
92 | MP0005000_abnormal_immune_tolerance | 0.84627680 |
93 | MP0009333_abnormal_splenocyte_physiolog | 0.82820307 |
94 | MP0005464_abnormal_platelet_physiology | 0.82430726 |
95 | MP0002896_abnormal_bone_mineralization | 0.81840093 |
96 | MP0005165_increased_susceptibility_to | 0.81598580 |
97 | MP0005058_abnormal_lysosome_morphology | 0.81041603 |
98 | MP0002148_abnormal_hypersensitivity_rea | 0.80515589 |
99 | MP0003436_decreased_susceptibility_to | 0.78871615 |
100 | MP0005220_abnormal_exocrine_pancreas | 0.77963265 |
101 | MP0005408_hypopigmentation | 0.77058164 |
102 | MP0005375_adipose_tissue_phenotype | 0.74649291 |
103 | MP0001661_extended_life_span | 0.73655515 |
104 | MP0002971_abnormal_brown_adipose | 0.72717452 |
105 | MP0009765_abnormal_xenobiotic_induced | 0.71779135 |
106 | MP0005376_homeostasis/metabolism_phenot | 0.70994563 |
107 | MP0003724_increased_susceptibility_to | 0.70656807 |
108 | * MP0002078_abnormal_glucose_homeostasis | 0.68051515 |
109 | MP0010234_abnormal_vibrissa_follicle | 0.67914516 |
110 | MP0005334_abnormal_fat_pad | 0.66780935 |
111 | MP0002928_abnormal_bile_duct | 0.66619159 |
112 | MP0005666_abnormal_adipose_tissue | 0.65626740 |
113 | MP0006036_abnormal_mitochondrial_physio | 0.64281108 |
114 | MP0005084_abnormal_gallbladder_morpholo | 0.63082931 |
115 | MP0003638_abnormal_response/metabolism_ | 0.63019920 |
116 | MP0003690_abnormal_glial_cell | 0.62299784 |
117 | MP0009384_cardiac_valve_regurgitation | 0.59878448 |
118 | MP0004043_abnormal_pH_regulation | 0.59402079 |
119 | MP0001853_heart_inflammation | 0.58619896 |
120 | MP0001845_abnormal_inflammatory_respons | 0.55453553 |
121 | MP0002796_impaired_skin_barrier | 0.55152217 |
122 | MP0001765_abnormal_ion_homeostasis | 0.54966585 |
123 | MP0005535_abnormal_body_temperature | 0.54539320 |
124 | MP0003075_altered_response_to | 0.53309592 |
125 | MP0005023_abnormal_wound_healing | 0.52825144 |
126 | MP0004264_abnormal_extraembryonic_tissu | 0.51703433 |
127 | MP0005266_abnormal_metabolism | 0.50579848 |
128 | MP0005166_decreased_susceptibility_to | 0.50009924 |
129 | MP0004782_abnormal_surfactant_physiolog | 0.49194371 |
130 | MP0004947_skin_inflammation | 0.48994358 |
131 | MP0002060_abnormal_skin_morphology | 0.47191458 |
132 | MP0002135_abnormal_kidney_morphology | 0.46206563 |
133 | MP0009115_abnormal_fat_cell | 0.46176328 |
134 | MP0002876_abnormal_thyroid_physiology | 0.45989626 |
135 | MP0008873_increased_physiological_sensi | 0.44994119 |
136 | MP0000249_abnormal_blood_vessel | 0.44749098 |
137 | MP0009053_abnormal_anal_canal | 0.43964460 |
138 | MP0000639_abnormal_adrenal_gland | 0.43910097 |
139 | MP0003566_abnormal_cell_adhesion | 0.42954410 |
140 | MP0005167_abnormal_blood-brain_barrier | 0.42734777 |
141 | MP0005448_abnormal_energy_balance | 0.41714903 |
142 | MP0000230_abnormal_systemic_arterial | 0.41632999 |
143 | MP0003329_amyloid_beta_deposits | 0.41266601 |
144 | * MP0002168_other_aberrant_phenotype | 0.40809105 |
145 | MP0006082_CNS_inflammation | 0.40648721 |
146 | * MP0005395_other_phenotype | 0.40110470 |
147 | MP0003453_abnormal_keratinocyte_physiol | 0.39657550 |
148 | MP0002166_altered_tumor_susceptibility | 0.37813492 |
149 | MP0010155_abnormal_intestine_physiology | 0.37631639 |
150 | MP0002419_abnormal_innate_immunity | 0.37267058 |
151 | MP0001915_intracranial_hemorrhage | 0.36332748 |
152 | MP0008874_decreased_physiological_sensi | 0.36084732 |
153 | MP0003953_abnormal_hormone_level | 0.35997225 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.66223896 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.51334847 |
3 | Intrahepatic cholestasis (HP:0001406) | 6.44842294 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.07870308 |
5 | Xanthomatosis (HP:0000991) | 5.98441751 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 5.70702399 |
7 | Hypobetalipoproteinemia (HP:0003563) | 5.33680141 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.05433824 |
9 | Complement deficiency (HP:0004431) | 4.82514642 |
10 | Joint hemorrhage (HP:0005261) | 4.67378701 |
11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.40166547 |
12 | * Hyperammonemia (HP:0001987) | 4.36054115 |
13 | Hypolipoproteinemia (HP:0010981) | 4.27608367 |
14 | Ketosis (HP:0001946) | 4.26279415 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.16866879 |
16 | Hyperglycinuria (HP:0003108) | 4.16776353 |
17 | Epidermoid cyst (HP:0200040) | 4.02949263 |
18 | Hypoalphalipoproteinemia (HP:0003233) | 4.02726041 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.00925750 |
20 | Hyperglycinemia (HP:0002154) | 3.99453707 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.95540413 |
22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94974038 |
23 | Abnormality of glycine metabolism (HP:0010895) | 3.94974038 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89902972 |
25 | Hypoglycemic coma (HP:0001325) | 3.83897294 |
26 | Fat malabsorption (HP:0002630) | 3.67963781 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.62294687 |
28 | Abnormality of complement system (HP:0005339) | 3.58800996 |
29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54299337 |
30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50952334 |
31 | Flat acetabular roof (HP:0003180) | 3.48570908 |
32 | Hypercholesterolemia (HP:0003124) | 3.42857082 |
33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.40766402 |
34 | Ketoacidosis (HP:0001993) | 3.29174788 |
35 | Thin bony cortex (HP:0002753) | 3.22124313 |
36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.20207822 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.18196260 |
38 | J-shaped sella turcica (HP:0002680) | 3.16047572 |
39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.12208104 |
40 | Myocardial infarction (HP:0001658) | 3.10022489 |
41 | Abnormality of purine metabolism (HP:0004352) | 3.09928533 |
42 | Gout (HP:0001997) | 3.09767153 |
43 | Hyperbilirubinemia (HP:0002904) | 3.01178616 |
44 | Hepatocellular carcinoma (HP:0001402) | 2.97742026 |
45 | Systemic lupus erythematosus (HP:0002725) | 2.87110092 |
46 | Vascular calcification (HP:0004934) | 2.86085437 |
47 | Delayed CNS myelination (HP:0002188) | 2.83257803 |
48 | Dysostosis multiplex (HP:0000943) | 2.80226309 |
49 | Asymmetry of the thorax (HP:0001555) | 2.77620992 |
50 | Steatorrhea (HP:0002570) | 2.70947768 |
51 | Metabolic acidosis (HP:0001942) | 2.68696836 |
52 | Abnormality of serum amino acid levels (HP:0003112) | 2.65703085 |
53 | Spastic diplegia (HP:0001264) | 2.64664921 |
54 | Mucopolysacchariduria (HP:0008155) | 2.64449176 |
55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.64449176 |
56 | Dicarboxylic aciduria (HP:0003215) | 2.64428695 |
57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64428695 |
58 | Skin nodule (HP:0200036) | 2.62285189 |
59 | Cardiovascular calcification (HP:0011915) | 2.61428663 |
60 | Abdominal distention (HP:0003270) | 2.61303897 |
61 | Esophageal varix (HP:0002040) | 2.61195959 |
62 | Generalized aminoaciduria (HP:0002909) | 2.53104356 |
63 | Glomerulonephritis (HP:0000099) | 2.50769013 |
64 | Spontaneous abortion (HP:0005268) | 2.50717379 |
65 | Mitral stenosis (HP:0001718) | 2.49730912 |
66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45772649 |
67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45772649 |
68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45772649 |
69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45542051 |
70 | Eczematoid dermatitis (HP:0000976) | 2.43989057 |
71 | Right ventricular cardiomyopathy (HP:0011663) | 2.41731665 |
72 | Alkalosis (HP:0001948) | 2.36800075 |
73 | Distal lower limb muscle weakness (HP:0009053) | 2.33489094 |
74 | Broad face (HP:0000283) | 2.32719004 |
75 | Hypochromic microcytic anemia (HP:0004840) | 2.32449293 |
76 | Malnutrition (HP:0004395) | 2.30903269 |
77 | Gingival bleeding (HP:0000225) | 2.28960432 |
78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28299163 |
79 | Osteolytic defects of the hand bones (HP:0009699) | 2.28299163 |
80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28230416 |
81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28230416 |
82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28230416 |
83 | Hypoglycemic seizures (HP:0002173) | 2.26288009 |
84 | Neonatal onset (HP:0003623) | 2.24671043 |
85 | Proximal tubulopathy (HP:0000114) | 2.24552690 |
86 | Hydroxyprolinuria (HP:0003080) | 2.23984207 |
87 | Abnormality of proline metabolism (HP:0010907) | 2.23984207 |
88 | Irritability (HP:0000737) | 2.22158959 |
89 | Increased cerebral lipofuscin (HP:0011813) | 2.21751871 |
90 | Late onset (HP:0003584) | 2.21098399 |
91 | * Lethargy (HP:0001254) | 2.21006076 |
92 | Hyperactive renin-angiotensin system (HP:0000841) | 2.20441863 |
93 | Menorrhagia (HP:0000132) | 2.20224581 |
94 | Amyloidosis (HP:0011034) | 2.16452462 |
95 | Vertebral compression fractures (HP:0002953) | 2.16139929 |
96 | Pancreatitis (HP:0001733) | 2.15577439 |
97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15184682 |
98 | Sensorimotor neuropathy (HP:0007141) | 2.14909517 |
99 | Prolonged bleeding time (HP:0003010) | 2.12705641 |
100 | Hemorrhage of the eye (HP:0011885) | 2.10656411 |
101 | Increased purine levels (HP:0004368) | 2.09826592 |
102 | Hyperuricemia (HP:0002149) | 2.09826592 |
103 | Hyperacusis (HP:0010780) | 2.08467596 |
104 | Acanthocytosis (HP:0001927) | 2.07331962 |
105 | Thrombophlebitis (HP:0004418) | 2.06504866 |
106 | Nephritis (HP:0000123) | 2.05294628 |
107 | Hyperparathyroidism (HP:0000843) | 2.05261971 |
108 | Abnormal cartilage morphology (HP:0002763) | 2.04798419 |
109 | Vomiting (HP:0002013) | 2.03546521 |
110 | Abnormal gallbladder morphology (HP:0012437) | 2.01242380 |
111 | Sparse lateral eyebrow (HP:0005338) | 2.01150673 |
112 | Cholelithiasis (HP:0001081) | 2.00577361 |
113 | Enlarged kidneys (HP:0000105) | 2.00332180 |
114 | Germ cell neoplasia (HP:0100728) | 1.97431883 |
115 | Colitis (HP:0002583) | 1.96320648 |
116 | Rickets (HP:0002748) | 1.96314422 |
117 | Bone pain (HP:0002653) | 1.95159348 |
118 | Cervical subluxation (HP:0003308) | 1.95138570 |
119 | Increased serum ferritin (HP:0003281) | 1.95133223 |
120 | Interstitial pulmonary disease (HP:0006530) | 1.95063971 |
121 | Impaired platelet aggregation (HP:0003540) | 1.94691505 |
122 | Abnormal platelet function (HP:0011869) | 1.94691505 |
123 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94482935 |
124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92104852 |
125 | Hypophosphatemia (HP:0002148) | 1.91942003 |
126 | Epistaxis (HP:0000421) | 1.90951167 |
127 | Abnormality of iron homeostasis (HP:0011031) | 1.90521013 |
128 | Protrusio acetabuli (HP:0003179) | 1.89010237 |
129 | Cholecystitis (HP:0001082) | 1.86554638 |
130 | Abnormal gallbladder physiology (HP:0012438) | 1.86554638 |
131 | Nausea (HP:0002018) | 1.86314775 |
132 | Renal cortical cysts (HP:0000803) | 1.85064341 |
133 | Chronic diarrhea (HP:0002028) | 1.84367281 |
134 | Deformed sella turcica (HP:0002681) | 1.82078612 |
135 | Glycosuria (HP:0003076) | 1.81963861 |
136 | Abnormality of urine glucose concentration (HP:0011016) | 1.81963861 |
137 | Opisthotonus (HP:0002179) | 1.81534094 |
138 | Cellulitis (HP:0100658) | 1.81385372 |
139 | Coarse hair (HP:0002208) | 1.80850720 |
140 | Spinal cord compression (HP:0002176) | 1.80745991 |
141 | Pigmentary retinal degeneration (HP:0001146) | 1.80296058 |
142 | Spondylolisthesis (HP:0003302) | 1.79095619 |
143 | Gingivitis (HP:0000230) | 1.79031825 |
144 | Cerebral edema (HP:0002181) | 1.78905208 |
145 | Polycythemia (HP:0001901) | 1.78670097 |
146 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77134186 |
147 | Cerebral aneurysm (HP:0004944) | 1.76865243 |
148 | Hypertriglyceridemia (HP:0002155) | 1.76435662 |
149 | Gastrointestinal inflammation (HP:0004386) | 1.75899651 |
150 | Severe short stature (HP:0003510) | 1.75223548 |
151 | Abnormality of the thoracic spine (HP:0100711) | 1.75159479 |
152 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74262842 |
153 | Aneurysm (HP:0002617) | 1.73569903 |
154 | Distal lower limb amyotrophy (HP:0008944) | 1.73506366 |
155 | Abnormality of carpal bone ossification (HP:0006257) | 1.73087783 |
156 | Testicular neoplasm (HP:0010788) | 1.72880980 |
157 | Reticulocytosis (HP:0001923) | 1.72722113 |
158 | Nephrolithiasis (HP:0000787) | 1.72617285 |
159 | Abnormality of the gastric mucosa (HP:0004295) | 1.72391577 |
160 | Micronodular cirrhosis (HP:0001413) | 1.68836911 |
161 | Visceral angiomatosis (HP:0100761) | 1.68310521 |
162 | Recurrent abscess formation (HP:0002722) | 1.68073952 |
163 | Short nail (HP:0001799) | 1.67838456 |
164 | Polygenic inheritance (HP:0010982) | 1.66280217 |
165 | Hemangiomatosis (HP:0007461) | 1.63238979 |
166 | Inflammation of the large intestine (HP:0002037) | 1.63196302 |
167 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.62622821 |
168 | Abnormality of macrophages (HP:0004311) | 1.62065010 |
169 | Protuberant abdomen (HP:0001538) | 1.61964590 |
170 | Blue sclerae (HP:0000592) | 1.61732706 |
171 | Vacuolated lymphocytes (HP:0001922) | 1.61391127 |
172 | Abnormality of the fingertips (HP:0001211) | 1.61387231 |
173 | Stroke (HP:0001297) | 1.61126470 |
174 | Abnormal platelet volume (HP:0011876) | 1.60228090 |
175 | Growth hormone excess (HP:0000845) | 1.59970030 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.28589287 |
2 | ERN1 | 4.49557215 |
3 | FGFR4 | 3.92577809 |
4 | SIK1 | 3.47742197 |
5 | TRIB3 | 3.17171358 |
6 | EPHA2 | 2.93494639 |
7 | PRPF4B | 2.69927495 |
8 | PKN2 | 2.63977432 |
9 | SMG1 | 2.62844867 |
10 | TAOK3 | 2.38437101 |
11 | SCYL2 | 2.37058294 |
12 | TYK2 | 2.12634440 |
13 | PTK6 | 2.01520746 |
14 | MST1R | 2.00162454 |
15 | INSRR | 1.87042460 |
16 | RPS6KB2 | 1.73428091 |
17 | FLT3 | 1.69942454 |
18 | MAP3K10 | 1.68080185 |
19 | ICK | 1.63991025 |
20 | EPHB1 | 1.60512408 |
21 | TGFBR2 | 1.56952046 |
22 | CDK12 | 1.54435455 |
23 | ERBB4 | 1.53647142 |
24 | MAPK11 | 1.48141185 |
25 | PIK3CA | 1.44847382 |
26 | NEK9 | 1.42577713 |
27 | FRK | 1.38737722 |
28 | RIPK4 | 1.38472339 |
29 | TRPM7 | 1.37964263 |
30 | LATS1 | 1.37200870 |
31 | MAP2K3 | 1.35994197 |
32 | PIK3CG | 1.35688649 |
33 | KDR | 1.33789642 |
34 | MAP4K1 | 1.33776321 |
35 | TIE1 | 1.33756041 |
36 | TBK1 | 1.31892018 |
37 | JAK1 | 1.30129244 |
38 | CAMK1D | 1.29771641 |
39 | WNK4 | 1.23439916 |
40 | GRK6 | 1.21988570 |
41 | CDK6 | 1.21735000 |
42 | JAK2 | 1.19365070 |
43 | RIPK1 | 1.17131770 |
44 | TESK2 | 1.14311153 |
45 | MAP3K7 | 1.12892837 |
46 | TESK1 | 1.08819005 |
47 | IRAK3 | 1.05082013 |
48 | CSK | 1.04363950 |
49 | NME2 | 1.01406094 |
50 | MAP3K3 | 1.01324028 |
51 | FGFR3 | 1.00431417 |
52 | PRKAA2 | 1.00343671 |
53 | LRRK2 | 0.98372722 |
54 | PAK4 | 0.97700566 |
55 | MAP3K14 | 0.95271245 |
56 | MAP3K13 | 0.93538681 |
57 | TAOK1 | 0.93310916 |
58 | EPHA3 | 0.92699184 |
59 | ABL2 | 0.92595244 |
60 | RPS6KA2 | 0.91191366 |
61 | EEF2K | 0.91028328 |
62 | MAP2K4 | 0.89290148 |
63 | PRKD2 | 0.88633260 |
64 | TNK2 | 0.85378957 |
65 | KIT | 0.82664250 |
66 | FGFR2 | 0.81479356 |
67 | DYRK1B | 0.80905125 |
68 | ERBB2 | 0.79564446 |
69 | PTK2 | 0.79172577 |
70 | HIPK2 | 0.77884611 |
71 | SGK3 | 0.77843372 |
72 | EIF2AK1 | 0.77796325 |
73 | MAPK15 | 0.77411681 |
74 | MAPK4 | 0.76567878 |
75 | CDC42BPA | 0.75834878 |
76 | MET | 0.75612023 |
77 | IKBKE | 0.74814673 |
78 | CSF1R | 0.74704585 |
79 | PDGFRA | 0.74410558 |
80 | PDK1 | 0.73570489 |
81 | GSK3A | 0.73362704 |
82 | NEK6 | 0.72803491 |
83 | RPS6KC1 | 0.70994113 |
84 | RPS6KL1 | 0.70994113 |
85 | PRKG2 | 0.70250388 |
86 | TAOK2 | 0.68793725 |
87 | STK10 | 0.67632217 |
88 | WNK3 | 0.67313409 |
89 | MAP2K2 | 0.65976699 |
90 | JAK3 | 0.65682288 |
91 | IRAK4 | 0.65098263 |
92 | GRK1 | 0.64778748 |
93 | ZAP70 | 0.64404096 |
94 | CAMK1G | 0.61726833 |
95 | MTOR | 0.58262522 |
96 | MAPK12 | 0.57613544 |
97 | MAP3K11 | 0.57005841 |
98 | MAPKAPK2 | 0.56233444 |
99 | RPS6KA6 | 0.55144494 |
100 | PRKACG | 0.55061781 |
101 | TTN | 0.53756591 |
102 | BTK | 0.52160410 |
103 | FES | 0.51543462 |
104 | MAP2K1 | 0.51510934 |
105 | CDK7 | 0.51287591 |
106 | BMX | 0.50399251 |
107 | PRKAA1 | 0.50332633 |
108 | ILK | 0.49924990 |
109 | MAP3K2 | 0.49900578 |
110 | STK38L | 0.49871088 |
111 | HCK | 0.47697621 |
112 | CDK4 | 0.47666228 |
113 | PRKD3 | 0.47238933 |
114 | CHUK | 0.46591366 |
115 | PDPK1 | 0.46565099 |
116 | MAP2K6 | 0.46374272 |
117 | IRAK1 | 0.46025429 |
118 | BLK | 0.45955917 |
119 | PAK2 | 0.45691546 |
120 | MAPK7 | 0.44987817 |
121 | MELK | 0.44845954 |
122 | MATK | 0.44777995 |
123 | PRKCZ | 0.44716480 |
124 | ITK | 0.43153446 |
125 | STK3 | 0.42759691 |
126 | IKBKB | 0.42588759 |
127 | RET | 0.42517893 |
128 | IGF1R | 0.41826001 |
129 | STK39 | 0.41356971 |
130 | MYLK | 0.41337150 |
131 | EGFR | 0.40245618 |
132 | SGK2 | 0.40025832 |
133 | PDGFRB | 0.39489956 |
134 | TEC | 0.39444628 |
135 | BMPR2 | 0.39261354 |
136 | PINK1 | 0.38940685 |
137 | MAPKAPK3 | 0.38590398 |
138 | PIM1 | 0.37415856 |
139 | OXSR1 | 0.35811622 |
140 | LMTK2 | 0.35694145 |
141 | DAPK2 | 0.34513480 |
142 | FER | 0.34369080 |
143 | PDK4 | 0.33893342 |
144 | PDK3 | 0.33893342 |
145 | MAP3K1 | 0.32592298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.12277236 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.61185969 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56526066 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.14923338 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88432404 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68476032 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.64011764 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61994621 |
9 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.61884621 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59001898 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.54963237 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51811582 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35522969 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16525905 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.06791759 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02551182 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01375324 |
18 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94252216 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89721880 |
20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88746749 |
21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.83667262 |
22 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82990562 |
23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82542550 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81508318 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79259266 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77408020 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74614979 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71391416 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65241921 |
30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64947994 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.59160547 |
32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52727416 |
33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50291371 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48814135 |
35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47441564 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46829153 |
37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44683486 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42755087 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40134344 |
40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36542382 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34637780 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.28979345 |
43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26040751 |
44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24468847 |
45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24185444 |
46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19505431 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18747392 |
48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17970455 |
49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17923126 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15419208 |
51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15110041 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14978651 |
53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13871416 |
54 | Thyroid cancer_Homo sapiens_hsa05216 | 1.12342196 |
55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11472130 |
56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04998937 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04698605 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04248491 |
59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04106255 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 1.03772817 |
61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03763661 |
62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99108330 |
63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.97713609 |
64 | Platelet activation_Homo sapiens_hsa04611 | 0.97681219 |
65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94435278 |
66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93831615 |
67 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93510904 |
68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93294535 |
69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89560841 |
70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88270442 |
71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87590497 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85836014 |
73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84725454 |
74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84581284 |
75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84402809 |
76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83510875 |
77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83103372 |
78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82531942 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80843259 |
80 | Influenza A_Homo sapiens_hsa05164 | 0.80407612 |
81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78153809 |
82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76789061 |
83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75977536 |
84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75834631 |
85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75481771 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75423641 |
87 | Hepatitis B_Homo sapiens_hsa05161 | 0.73958129 |
88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73206508 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72735630 |
90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71297902 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70820231 |
92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68651955 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68484585 |
94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67154842 |
95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66666155 |
96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64498873 |
97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62904006 |
98 | Prostate cancer_Homo sapiens_hsa05215 | 0.62247816 |
99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60730024 |
100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58560536 |
101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57710264 |
102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57512703 |
103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56548753 |
104 | Measles_Homo sapiens_hsa05162 | 0.56498506 |
105 | Focal adhesion_Homo sapiens_hsa04510 | 0.55945445 |
106 | Tuberculosis_Homo sapiens_hsa05152 | 0.52017744 |
107 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51982739 |
108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51519147 |
109 | Apoptosis_Homo sapiens_hsa04210 | 0.51436197 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51207917 |
111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49569646 |
112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48506209 |
113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48318474 |
114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38716297 |
115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38306619 |
116 | * Insulin resistance_Homo sapiens_hsa04931 | 0.35855766 |
117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35132893 |
118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33895521 |
119 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30461407 |
120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27757516 |
121 | Prion diseases_Homo sapiens_hsa05020 | 0.19820801 |
122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18507136 |
123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14262301 |
124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11799737 |
125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.08929292 |
126 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05205382 |
127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03579908 |
128 | Lysosome_Homo sapiens_hsa04142 | 0.02650510 |
129 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02522901 |
130 | Other glycan degradation_Homo sapiens_hsa00511 | 0.01845433 |
131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1839146 |
132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1709305 |
133 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1565777 |
134 | Bladder cancer_Homo sapiens_hsa05219 | -0.1557809 |
135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1545149 |
136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1355148 |
137 | Pertussis_Homo sapiens_hsa05133 | -0.1292696 |
138 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1146559 |
139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0990918 |
140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0771284 |
141 | Amoebiasis_Homo sapiens_hsa05146 | -0.0699535 |
142 | Mineral absorption_Homo sapiens_hsa04978 | -0.0582727 |
143 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0549311 |
144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0528081 |
145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0363968 |
146 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0347907 |
147 | Hepatitis C_Homo sapiens_hsa05160 | -0.0345471 |